Health
Thousands walk 3 miles at Jones Beach to raise funds for pancreatic cancer research
This is a hopeful moment in pancreatic cancer research, Tantawi said. A new drug, Daraxonrasib (whose brand name is Rasonque, made by Revolution Medicine) was approved by the FDA in August. In a clinical trial, researchers found the drug doubled survival times for patients with previously treated metastatic cancer, compared with chemotherapy.
approvedmortality & survivalapprovalmedium evidence82% progress confidence
Read the source →
newsday.com · 20261004T194703Z